CN113632905A - 一种人参葛根固体饮料及其制备方法 - Google Patents
一种人参葛根固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN113632905A CN113632905A CN202110651518.1A CN202110651518A CN113632905A CN 113632905 A CN113632905 A CN 113632905A CN 202110651518 A CN202110651518 A CN 202110651518A CN 113632905 A CN113632905 A CN 113632905A
- Authority
- CN
- China
- Prior art keywords
- parts
- ginseng
- radix puerariae
- kudzu root
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000208340 Araliaceae Species 0.000 title claims abstract description 58
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 58
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 58
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 58
- 235000013361 beverage Nutrition 0.000 title claims abstract description 16
- 239000007787 solid Substances 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 241000208688 Eucommia Species 0.000 claims abstract description 25
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 22
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 22
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 20
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 19
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 19
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 19
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 19
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 19
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 19
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 19
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 19
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 19
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 19
- 229940087559 grape seed Drugs 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 8
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 8
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 8
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 5
- 235000013399 edible fruits Nutrition 0.000 claims description 25
- 244000046146 Pueraria lobata Species 0.000 claims description 21
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 21
- 244000241838 Lycium barbarum Species 0.000 claims description 12
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 12
- 235000015468 Lycium chinense Nutrition 0.000 claims description 12
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 7
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 7
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 230000008014 freezing Effects 0.000 claims description 7
- 238000007710 freezing Methods 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 7
- 230000003179 granulation Effects 0.000 claims description 7
- 240000006365 Vitis vinifera Species 0.000 claims 2
- 238000000034 method Methods 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 abstract description 18
- 239000008280 blood Substances 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 8
- 230000007812 deficiency Effects 0.000 abstract description 7
- 206010020772 Hypertension Diseases 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 4
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 239000010839 body fluid Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 210000005036 nerve Anatomy 0.000 abstract description 3
- 230000001914 calming effect Effects 0.000 abstract description 2
- 230000009982 effect on human Effects 0.000 abstract description 2
- 230000004438 eyesight Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 241001092040 Crataegus Species 0.000 description 14
- 210000003734 kidney Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 6
- 241000219095 Vitis Species 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000009475 tablet pressing Methods 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000013116 chronic cough Diseases 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940087603 grape seed extract Drugs 0.000 description 2
- 235000002532 grape seed extract Nutrition 0.000 description 2
- 244000237330 gutta percha tree Species 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000001717 vitis vinifera seed extract Substances 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- ZJSJQWDXAYNLNS-UHFFFAOYSA-N (+) pinoresinol-4,4'-di-O-beta-D-glucopyranoside Natural products COC1=CC(C2C3C(C(OC3)C=3C=C(OC)C(OC4C(C(O)C(O)C(CO)O4)O)=CC=3)CO2)=CC=C1OC1OC(CO)C(O)C(O)C1O ZJSJQWDXAYNLNS-UHFFFAOYSA-N 0.000 description 1
- ZJSJQWDXAYNLNS-FUPWJLLWSA-N (2s,3r,4s,5s,6r)-2-[4-[(3s,3ar,6s,6ar)-6-[3-methoxy-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound COC1=CC([C@@H]2[C@@H]3[C@@H]([C@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=CC=3)CO2)=CC=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O ZJSJQWDXAYNLNS-FUPWJLLWSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- UTDFQMAXCUGNJR-UHFFFAOYSA-N aucubin Natural products OCC1OC(Oc2ccoc2C3C(O)CCC3O)C(O)C(O)C1O UTDFQMAXCUGNJR-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- -1 stomach invigorating Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种人参葛根固体饮料及其制作方法，先将人参、蛹虫草、杜仲雄花、绞股蓝、葛根、山楂子、葡萄籽和枸杞子在冷冻萃取技术的条件下精制，然后混合均匀后，依次进行制粒、干燥、压片处理即制得人参葛根压片；本发明以人参、杜仲雄花、绞股蓝、葡萄籽作为重要原料成分添加，适合高血压人群食用，各原料组分科学地搭配，各组分之间相互影响，取得协同作用，使得压片糖果具有降低血压，生津养元、养血排湿、调补气血、明目安神之功效；平衡阴阳，调理虚实，不会给身体带来不必要的副作用。
Description
技术领域
本发明涉及糖果技术领域，尤其是一种人参葛根固体饮料及其制备方法。
背景技术
高血压，是指以体循环动脉血压(收缩压和/或舒张压)增高为主要特征(收缩压≥140毫米汞柱，舒张压≥90毫米汞柱)，可伴有心、脑、肾等器官的功能或器质性损害的临床综合征。高血压是最常见的慢性病，也是心脑血管病最主要的危险因素。
糖果，是糖果糕点的一种，指以糖类为主要成份的一种小吃。若水果或坚果类食物裹上糖衣，则称为甜食(如糖葫芦)。
现有的糖果主要满足人的口腹之欲，甚至吃过量了，还会引发肥胖、高血糖等问题，对人体的负面影响也越来越明显。
发明内容
本发明的目的在于提供一种人参葛根固体饮料及其制备方法，以解决上述背景技术中提出的问题。
为实现上述目的，本发明提供如下技术方案：
一种人参葛根固体饮料，包括以下重量份的原料制成：
人参13-17份，蛹虫草8-12份，杜仲雄花28-32份，绞股蓝2-6份，葛根10-20份，山楂子18-22份，葡萄籽26-34份，枸杞子20-30份。
在进一步的实施例中，所述人参葛根压片糖果，包括以下重量份的原料制成：人参14-16份，蛹虫草9-11份，杜仲雄花29-31份，绞股蓝3-5份，葛根13-17份，山楂子 19-21份，葡萄籽28-32份，枸杞子23-27份。
在进一步的实施例中，所述人参葛根压片糖果，包括以下重量份的原料制成：人参15 份，蛹虫草10份，杜仲雄花30份，绞股蓝4份，葛根15份，山楂子20份，葡萄籽30 份，枸杞子25份。
人参，含多种皂甙和多糖类成分，浸出液可被皮肤缓慢吸收且无不良刺激，能扩张皮肤毛细血管，促进皮肤血液循环，增加皮肤营养，调节皮肤的水油平衡，防止皮肤脱水、硬化、起皱，人参活性物质抑制黑色素的还原性能，使皮肤洁白光滑，能增强皮肤弹性，使细胞获得新生，是护肤美容的极品。人参的肉质根为著名强壮滋补药，适用于调整血压、恢复心脏功能、神经衰弱及身体虚弱等症，也有祛痰、健胃、利尿、兴奋等功效。
蛹虫草，性味甘、平，入肺、肾二经。功效主治：1.益肾补阳，本品甘平，补肾阳，益精髓，用治肾阳不足，髓海空虚，眩晕耳鸣，健忘不寐，腰膝酸软，阳痿早泄等症。2.止血化痰，本品即补肾阳，有益肺阴，保肺益肾，秘经益气，对肺肾不足、久咳虚喘、劳嗽痰血者有较好疗效”。
杜仲雄花，“杜仲雄花”特含60多种有效植物成分，如木质素类，环烯醚萜类、苯丙素类活性物质(如京尼平甙酸、绿原酸、桃叶珊瑚甙)、松脂醇双糖甙、黄酮、生物碱、氨基酸、多糖以及矿质元素Zn、Mn、Cu、Fe、Ca、P、B、Mg、K等，其中氨基酸含量达21.47％，钙的含量达0.92％，锌含量达51mg/100g，分别是杜仲叶的1.8倍和5.2倍，有效成分最为全面，而且含量更高，杜仲雄花，汇集了所有杜仲的精华，可以说杜仲雄花具备植物杜仲所有的保健功效，而且对于“强肝、补肾、通便、安眠、降三高”的效果尤为显著。
绞股蓝，绞股蓝性寒、味苦，具有清热解毒、止咳清肺祛痰、养心安神、补气生精之功效，可用于降血压、降血脂、护肝、促进睡眠以及肠胃炎、气管炎、咽喉炎的治疗，并用于多种癌症的抗癌临床治疗。
葛根，甘、辛，凉。有解肌退热，透疹，生津止渴，升阳止泻之功。常用于表证发热，项背强痛，麻疹不透，热病口渴，阴虚消渴，热泻热痢，脾虚泄泻。
葡萄籽，防治心脏病、癌症、早衰、糖尿病、动脉硬化等100多种由自由基所引起的疾病，葡萄籽提取物(OPC)能有效清除体内多余的自由基，保护人体细胞组织免受自由基的氧化损伤，防治过敏、癌症、衰老等100多种与自由基有关的疾病，还具有加强和保护人体活性组织、稳定细胞膜以及抗酶活性(组胺脱羧酶)等生物特性。此外，OPC很好的生物利用度，易于被人体吸收；其它的抗氧化剂如硒、锗、胡萝卜素、超氧化物岐化酶 (SOD)不是效力太弱就是没有体内活性；葡萄籽提取物富含100多种有效物质，其中不饱和脂肪酸-----亚油酸(是一种人体必需但不能合成的)占68-76％居油料作物之首，它由不饱和到饱和状态要消耗20％的胆固醇，能够有效的降低血脂。
枸杞子，主治为滋肾，润肺，补肝，明目。治肝肾阴亏，腰膝酸软，头晕，目眩，目昏多泪，虚劳咳嗽，消渴，遗精。
另外，本发明还提供了一种人参葛根固体饮料的制作方法，包括以下步骤：
先将人参、蛹虫草、杜仲雄花、绞股蓝、葛根、山楂子、葡萄籽和枸杞子在冷冻萃取技术的条件下精制，然后混合均匀后，依次进行制粒、干燥、压片处理即制得人参葛根压片。
与现有技术相比，本发明的有益效果是：本发明以人参、杜仲雄花、绞股蓝、葡萄籽作为重要原料成分添加，适合高血压人群食用，各原料组分科学地搭配，各组分之间相互影响，取得协同作用，使得压片糖果具有降低血压，生津养元、养血排湿、调补气血、明目安神之功效；平衡阴阳，调理虚实，不会给身体带来不必要的副作用。
具体实施方式
在本发明的描述中，需要说明的是，除非另有明确的规定和限定，术语“安装”、“相连”、“连接”应做广义理解，例如，可以是固定连接，也可以是可拆卸连接，或一体地连接；可以是机械连接，也可以是电连接；可以是直接相连，也可以通过中间媒介间接相连，可以是两个元件内部的连通。对于本领域的普通技术人员而言，可以通过具体情况理解上述术语在本发明中的具体含义。
下面将结合本发明实施例中的，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
一种人参葛根固体饮料，包括以下重量份的原料制成：
人参13份，蛹虫草8份，杜仲雄花28份，绞股蓝2份，葛根10份，山楂子18份，葡萄籽26份，枸杞子20份。
制备人参葛根压片糖果时，先将人参、蛹虫草、杜仲雄花、绞股蓝、葛根、山楂子、葡萄籽和枸杞子在冷冻萃取技术的条件下精制，然后混合均匀后，依次进行制粒、干燥、压片处理即制得人参葛根压片。
实施例2
一种人参葛根固体饮料，包括以下重量份的原料制成：
人参17份，蛹虫草12份，杜仲雄花32份，绞股蓝6份，葛根20份，山楂子22份，葡萄籽34份，枸杞子30份。
制备人参葛根压片糖果时，先将人参、蛹虫草、杜仲雄花、绞股蓝、葛根、山楂子、葡萄籽和枸杞子在冷冻萃取技术的条件下精制，然后混合均匀后，依次进行制粒、干燥、压片处理即制得人参葛根压片。
实施例3
一种人参葛根固体饮料，包括以下重量份的原料制成：
人参14份，蛹虫草9份，杜仲雄花29份，绞股蓝3份，葛根13份，山楂子19份，葡萄籽28份，枸杞子23份。
制备人参葛根压片糖果时，先将人参、蛹虫草、杜仲雄花、绞股蓝、葛根、山楂子、葡萄籽和枸杞子在冷冻萃取技术的条件下精制，然后混合均匀后，依次进行制粒、干燥、压片处理即制得人参葛根压片。
实施例4
一种人参葛根固体饮料，包括以下重量份的原料制成：
人参16份，蛹虫草11份，杜仲雄花31份，绞股蓝5份，葛根17份，山楂子21份，葡萄籽32份，枸杞子27份。
制备人参葛根压片糖果时，先将人参、蛹虫草、杜仲雄花、绞股蓝、葛根、山楂子、葡萄籽和枸杞子在冷冻萃取技术的条件下精制，然后混合均匀后，依次进行制粒、干燥、压片处理即制得人参葛根压片。
实施例5
一种人参葛根固体饮料，包括以下重量份的原料制成：
人参15份，蛹虫草10份，杜仲雄花30份，绞股蓝4份，葛根15份，山楂子20份，葡萄籽30份，枸杞子25份。
制备人参葛根压片糖果时，先将人参、蛹虫草、杜仲雄花、绞股蓝、葛根、山楂子、葡萄籽和枸杞子在冷冻萃取技术的条件下精制，然后混合均匀后，依次进行制粒、干燥、压片处理即制得人参葛根压片。
对于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。不应将权利要求中的任何标记视为限制所涉及的权利要求。
此外，应当理解，虽然本说明书按照实施方式加以描述，但并非每个实施方式仅包含一个独立的技术方案，说明书的这种叙述方式仅仅是为清楚起见，本领域技术人员应当将说明书作为一个整体，各实施例中的技术方案也可以经适当组合，形成本领域技术人员可以理解的其他实施方式。
Claims (4)
1.一种人参葛根固体饮料，其特征在于，包括以下重量份的原料制成：
人参13-17份，蛹虫草8-12份，杜仲雄花28-32份，绞股蓝2-6份，葛根10-20份，山楂子18-22份，葡萄籽26-34份，枸杞子20-30份。
2.根据权利要求1所述的一种人参葛根固体饮料，其特征在于，包括以下重量份的原料制成：人参14-16份，蛹虫草9-11份，杜仲雄花29-31份，绞股蓝3-5份，葛根13-17份，山楂子19-21份，葡萄籽28-32份，枸杞子23-27份。
3.根据权利要求1所述的一种人参葛根固体饮料，其特征在于，包括以下重量份的原料制成：人参15份，蛹虫草10份，杜仲雄花30份，绞股蓝4份，葛根15份，山楂子20份，葡萄籽30份，枸杞子25份。
4.根据权利要求1或2或3所述的一种人参葛根固体饮料的制作方法，其特征在于，包括以下步骤：先将人参、蛹虫草、杜仲雄花、绞股蓝、葛根、山楂子、葡萄籽和枸杞子在冷冻萃取技术的条件下精制，然后混合均匀后，依次进行制粒、干燥、压片处理即制得人参葛根压片。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110651518.1A CN113632905A (zh) | 2021-06-10 | 2021-06-10 | 一种人参葛根固体饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110651518.1A CN113632905A (zh) | 2021-06-10 | 2021-06-10 | 一种人参葛根固体饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113632905A true CN113632905A (zh) | 2021-11-12 |
Family
ID=78415930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110651518.1A Pending CN113632905A (zh) | 2021-06-10 | 2021-06-10 | 一种人参葛根固体饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113632905A (zh) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301427A (zh) * | 2007-05-09 | 2008-11-12 | 成都自豪药业有限公司 | 一种药物组合物及其制备方法和用途 |
| CN104856009A (zh) * | 2015-04-23 | 2015-08-26 | 贵州广济堂药业有限公司 | 一种杜仲雄花保健品 |
| CN106070985A (zh) * | 2016-06-22 | 2016-11-09 | 上海同舟共济生物科技有限公司 | 一种杜仲雄花压片糖果及其生产工艺 |
| CN106860680A (zh) * | 2017-03-17 | 2017-06-20 | 广东说养自然医学技术有限公司 | 金花人参压片糖果及其制备方法 |
| CN108324746A (zh) * | 2018-05-02 | 2018-07-27 | 冯显春 | 一种用蛹虫草和杜仲雄花制成的治未病饮片及其制备方法 |
| CN110477177A (zh) * | 2019-08-15 | 2019-11-22 | 朱保全 | 一种人参葛根压片糖果及其制备方法 |
| CN111759878A (zh) * | 2020-08-20 | 2020-10-13 | 鲁雪梅 | 一种降血糖的中药组合物及其制备方法 |
-
2021
- 2021-06-10 CN CN202110651518.1A patent/CN113632905A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101301427A (zh) * | 2007-05-09 | 2008-11-12 | 成都自豪药业有限公司 | 一种药物组合物及其制备方法和用途 |
| CN104856009A (zh) * | 2015-04-23 | 2015-08-26 | 贵州广济堂药业有限公司 | 一种杜仲雄花保健品 |
| CN106070985A (zh) * | 2016-06-22 | 2016-11-09 | 上海同舟共济生物科技有限公司 | 一种杜仲雄花压片糖果及其生产工艺 |
| CN106860680A (zh) * | 2017-03-17 | 2017-06-20 | 广东说养自然医学技术有限公司 | 金花人参压片糖果及其制备方法 |
| CN108324746A (zh) * | 2018-05-02 | 2018-07-27 | 冯显春 | 一种用蛹虫草和杜仲雄花制成的治未病饮片及其制备方法 |
| CN110477177A (zh) * | 2019-08-15 | 2019-11-22 | 朱保全 | 一种人参葛根压片糖果及其制备方法 |
| CN111759878A (zh) * | 2020-08-20 | 2020-10-13 | 鲁雪梅 | 一种降血糖的中药组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106722963A (zh) | 一种素食餐 | |
| CN103125710B (zh) | 一种女士用八珍茶 | |
| CN111264735A (zh) | 一种扶正固本提高免疫力防控疫毒的功能饮料 | |
| CN105925404A (zh) | 一种sod保健葡萄酒 | |
| CN105532991A (zh) | 一种具有养颜美容功能的复合黑茶及其制备方法 | |
| KR20070013114A (ko) | 차 조성물 | |
| CN103027139A (zh) | 四季养生保健茶 | |
| CN103725467B (zh) | 一种高丽参红葡萄酒的制备方法 | |
| CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
| CN107156820A (zh) | 全面调理女性产后受损体质的营养食品及其制备方法 | |
| CN111249410A (zh) | 一种保肝解毒排脂防治肝损伤恢复肝功能的药膳饮料 | |
| KR101999675B1 (ko) | 관상동맥성 심장질환의 예방과 치료용 생약조성물 | |
| CN107384680B (zh) | 一种百香果龙眼果酒及其酿造方法 | |
| CN105410243A (zh) | 一种四季养生保健茶 | |
| CN105077501A (zh) | 一种青年女性用减肥饮料 | |
| KR101163069B1 (ko) | 주름 및 잡티 개선용 화장료 조성물 및 이의 제조방법 | |
| KR101227063B1 (ko) | 혈액순환 개선용 식품 조성물 및 그 제조방법 | |
| CN113632905A (zh) | 一种人参葛根固体饮料及其制备方法 | |
| CN106857937A (zh) | 一种具有辅助降血压功效的龙胆槐菊茶饮料 | |
| CN108813500B (zh) | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 | |
| CN102973687B (zh) | 调节妇女内分泌平衡的口服液 | |
| CN105342923A (zh) | 一种预防嘴唇干裂的唇膏及其制备方法 | |
| CN111513157A (zh) | 一种含枸杞决明子的养生茶及其制作方法 | |
| CN110679935A (zh) | 一种牛蒡人参精华膏及其制备方法 | |
| CN106819253A (zh) | 排毒降脂茶及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20221103 Address after: 236,800 Room 102, Building 2, Zhumeng Community, Mudan Road, High tech Zone, Bozhou City, Anhui Province Applicant after: Bozhou Zhongrun Anjian Medical Technology Co.,Ltd. Address before: No. 415, Wansong East Road, Ruian City, Zhejiang Province 325200 Applicant before: Li Hongxing |
|
| TA01 | Transfer of patent application right |